Galderma S.A.

Clinical research in atopic dermatitis centers on moderate-to-severe disease across pediatric, adolescent, and adult populations. The sponsor’s studies examine treatment needs in patients whose symptoms remain insufficiently controlled with topical therapy, with attention to ongoing disease management and long-term use.

• Moderate-to-severe atopic dermatitis
• Pediatric dermatology
• Adolescent and adult skin disease
• Topical corticosteroid use

The therapeutic focus includes chronic inflammatory skin disease, with interest in symptom control, tolerability, and sustained treatment safety.